VinCRIStine Sulfate
VinCRIStine Sulfate Injection, USP
Approved
Approval ID
b22e4c8e-dbe1-4d4b-a026-e1812974071c
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 1, 2023
Manufacturers
FDA
Hospira, Inc.
DUNS: 141588017
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
VINCRISTINE SULFATE
PRODUCT DETAILS
NDC Product Code61703-309
Application NumberANDA071484
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateFebruary 1, 2023
Generic NameVINCRISTINE SULFATE
INGREDIENTS (5)
WATERInactive
Code: 059QF0KO0R
Classification: IACT
VINCRISTINE SULFATEActive
Quantity: 1 mg in 1 mL
Code: T5IRO3534A
Classification: ACTIB
MANNITOLInactive
Quantity: 100 mg in 1 mL
Code: 3OWL53L36A
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCF
Classification: IACT